Pila Pharma AB (publ) (STO:PILA)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.470
-0.030 (-2.00%)
Sep 4, 2026, 11:58 AM CET

Pila Pharma AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-16.77-17-11.24-9.93-26.78-17.21
Depreciation & Amortization
0.541.081.081.080.020.02
Loss (Gain) From Sale of Investments
8.758.753.08---
Other Operating Activities
---3.517.897.92
Change in Accounts Receivable
-12.3-0.070.160.07-0.06-0.16
Change in Accounts Payable
0.8-0.21-0.790.82-00.14
Change in Other Net Operating Assets
-1.810.82-0.11-0.39-0.16-0.07
Operating Cash Flow
-20.79-6.63-7.82-4.85-9.09-9.36
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---1.5--
Total Debt Issued
---1.5--
Short-Term Debt Repaid
------0.5
Long-Term Debt Repaid
----1.5--
Total Debt Repaid
----1.5--0.5
Net Debt Issued (Repaid)
------0.5
Issuance of Common Stock
35.3129.929.847.066.9248.54
Other Financing Activities
-12.34-12.28-3.08-3.5-18.8-12.37
Financing Cash Flow
22.9717.646.763.56-11.8835.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
2.1811-1.06-1.29-20.9726.3

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-5.12-3.47-4.66-2.44-5.76-5.88
Unlevered Free Cash Flow
-5.12-3.47-4.66-2.42-5.76-5.86

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-13.320.54-0.740.5-0.22-0.09